Immunome (IMNM) ROE US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
ROE, % | ? | 29.6% | -41.4% | -50.8% | -225.3% | -89.1% | -81.3% | |
Changes by years, y/y, % | -2pp | -71pp | -9pp | -174pp | +136pp |
Immunome. ROE, %
Immunome. ROE, changes, pp
Immunome (IMNM) ROE US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
ROE, % | ? | -215.9% | -284.5% | -368.3% | -88.9% | -81.3% | -81.3% | |
Changes by years, y/y, % | -130pp | -165pp | -208pp | +136pp | +135pp | |||
Changes by quarters, q/q, % | +9pp | -69pp | -84pp | +279pp | +8pp |